aadibio.com - WHWK Operatsion marja

Aadi Bio (WHWK) kompaniyasining korporativ logotipi

Operatsion marja Aadi Bioscience Inc (WHWK) kompaniyasining asosiy operatsion samaradorligini vizuallashtiradi, 0.00 esa ushbu ko'rsatkichning joriy qiymatini ko'rsatadi. Maqsadli terapiyalarning onkologik bazasi FDA tasdig'idan so'ng barcha tegishli bemorlarni saqlab qoladi. Kam uchraydigan sarkoma terapiyasi uchun patent monopoliya maqomini va yuqori daromadlilikni kafolatlaydi. Shu bilan birga, kompaniya qat'iy ekologik standartlarga rioya qilgan holda emissiyalarni filtrlash tizimlarini joriy qilmoqda.

WHWK: Aadi Bio Operatsion faoliyat rentabelligi 20.03.2025 - 19.11.2026

WHWK (Aadi Bioscience, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

Kompaniyaning har tomonlama tahlili:Aadi Bio, WHWK
Aadi Bioscience asosiy tovari

Operatsion marja barcha o'zgaruvchan va doimiy biznes operatsion xarajatlari chegirib tashlanganidan keyin qolgan tushum qismini belgilaydi va xarajatlarni boshqarish samaradorligining asosiy ko'rsatkichi bo'lib xizmat qiladi. Operatsion foydaga asoslangan savdo rentabelligining tahlili Fyarro tijoratlashtirilishi va onkologik kasalliklarni davolash uchun terapevtik ko'rsatmalarni kengaytirish bilan bog'liq xarajatlar kontekstida Aadi Bioscience Inc (WHWK) moliyaviy barqarorligini baholash imkonini beradi.

Raqobatchilar tahlili

Operatsion rentabellik BeiGene Ltd|Halozyme Therapeutics - Operatsion foyda marjasi|Sotuvning operatsion marjasi RVMD (Revolution Medicines Corp)|Operatsion foyda koeffitsiyenti AAPG|Operatsion rentabellik CG Oncology Therapeutics CGON|Operatsion foyda normasi URGN|BCAX: Sotuvning operatsion marjasi|PSNL: Operatsion rentabellik|Erasca (ERAS) - Operatsion rentabellik|DCTH - Operatsion faoliyat rentabelligi|YMAB (Y-mAbs Corp) - Operatsion marja|Sotuvning operatsion marjasi Aura Biosciences (AURA)|Operatsion rentabellik Candel Therapeutics Inc. (CADL)|Sotuvning operatsion marjasi Accuray, Inc. ARAY|Operatsion rentabellik sellaslifesciences.com SLS|Operatsion foyda normasi ACTU|CTOR - Operatsion rentabellik|Operatsion faoliyat rentabelligi tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Operatsion rentabellik|FATE: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TCRX|Operatsion rentabellik CSBR|Operatsion marja XBIT|Operatsion faoliyat rentabelligi CEL-SCI Corp.|Operatsion rentabellik ostherapies.com OSTX|RADX: Operatsion foyda bo'yicha sotuv rentabelligi|ARTV: Sotuvning operatsion marjasi|ANL (Adlai Nortye) - Operatsion foyda bo'yicha sotuv rentabelligi|Veru (VERU) - Operatsion rentabellik|Sotuvning operatsion marjasi Tempest Therapeutics Inc|Operatsion rentabellik Xilio Therapeutics|Operatsion foyda bo'yicha sotuv rentabelligi RENB (Renovaro Inc.)|Operatsion rentabellik Mural Oncology PLC (MURA)|Operatsion marja Kairos Pharma (KAPA)|Operatsion rentabellik onkuretherapeutics.com OKUR|GDTC: Operatsion foyda bo'yicha sotuv rentabelligi|CRIS: Sotuvning operatsion marjasi|apollomicsinc.com (APLM) - Sotuvning operatsion marjasi|THAR: Operatsion marja|Sotuvning operatsion marjasi Advanced Biomed Inc.|Sotuvning operatsion marjasi GNPX|Operatsion foyda bo'yicha sotuv rentabelligi CLDI (Calidi Biotherapeutics)|Operatsion marja SBFM|Xenetic Biosciences, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Salarius Pharmaceuticals SLRX|Operatsion marja purple-biotech.com PPBT|AONC - Operatsion rentabellik|BGNE: Operatsion rentabellik|CKPT: Operatsion marja|Elevation Oncology - Operatsion foyda normasi|ICAD (iCAD) - Operatsion marja|IKNA: Operatsion foyda normasi|Operatsion rentabellik Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Operatsion foyda normasi|Operatsion rentabellik MorphoSys Corporation MOR|NAYA: Operatsion foyda bo'yicha sotuv rentabelligi|Ascentage Pharma Group International - Operatsion marja